Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cronos Group Inc. stock logo
CRON
Cronos Group
$2.04
+0.7%
$1.86
$1.60
$2.66
$784.30M1.061.30 million shs552,738 shs
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$5.79
+0.5%
C$5.85
C$5.09
C$6.45
C$585.66M0.563,295 shs7,174 shs
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
$12.02
+0.6%
$11.49
$10.11
$12.96
N/AN/A81,893 shs44,679 shs
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
$10.58
-16.7%
$10.89
$8.79
$35.37
$4.41M1.149,920 shs4,713 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cronos Group Inc. stock logo
CRON
Cronos Group
+1.00%-2.42%+10.38%+1.00%-24.63%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-0.69%0.00%-2.70%+4.54%-2.87%
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
-0.58%+0.17%+5.48%-2.37%-1.73%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
+0.90%-2.81%-7.42%-24.63%-69.41%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cronos Group Inc. stock logo
CRON
Cronos Group
1.6375 of 5 stars
0.05.00.00.03.40.01.3
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
1.4932 of 5 stars
2.80.00.00.00.63.30.6
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cronos Group Inc. stock logo
CRON
Cronos Group
0.00
N/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
3.50
Strong BuyC$7.1523.49% Upside
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
0.00
N/AN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest RIV, CRON, GUD, and WEED Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetHold ➝ BuyC$6.50
3/25/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuyC$6.25 ➝ C$7.45
3/21/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
3/11/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Research Capitl
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cronos Group Inc. stock logo
CRON
Cronos Group
$124.59M6.30N/AN/A$2.87 per share0.71
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$348.70M1.68C$1.51 per share3.85C$7.65 per share0.76
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
$44.13MN/AN/AN/AN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cronos Group Inc. stock logo
CRON
Cronos Group
-$73.96M$0.13N/A67.831.74-42.65%-2.56%-2.47%8/14/2025 (Estimated)
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-C$30.73M-C$0.30N/AN/A-8.81%-4.04%0.51%N/A
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/A0.00N/AN/AN/AN/AN/A

Latest RIV, CRON, GUD, and WEED Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.01$0.02+$0.01$0.02$45.44 million$33.62 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AN/AN/AN/AN/A
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
$1.6613.82%-8.84%N/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/A

Latest RIV, CRON, GUD, and WEED Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/4/2025
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
monthly$0.127713%6/13/20256/13/20256/30/2025
4/3/2025
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
monthly$0.127713%6/13/20256/13/20256/30/2025
5/13/2025
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
$0.127712.72%5/15/20255/16/20255/30/2025
4/9/2025
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
$0.127714.71%4/15/20254/16/20254/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
24.24
23.05
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
7.52
3.36
1.79
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
12.58%
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
450385.41 million356.14 millionOptionable
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
725101.15 millionN/ANot Optionable
RiverNorth Opportunities Fund, Inc. stock logo
RIV
RiverNorth Opportunities Fund
N/AN/AN/ANot Optionable
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A345,000N/ANot Optionable

Recent News About These Companies

7 Best Marijuana Stocks and ETFs to Buy in 2025
6 Best-Performing ETFs of Last Week
Roundhill COIN WeeklyPay ETF (COIW)
Best & Worst ETF Zones of Q1
When (WEED) Moves Investors should Listen
(WEED) Pivots Trading Plans and Risk Controls
Top & Flop ETFs of 2024
(WEED) Long Term Investment Analysis
(WEED) Trading Advice
(WEED) Investment Analysis
(WEED) Investment Report
(WEED) Trading Signals
WEED Roundhill Cannabis ETF
(WEED) Trading Report
YBTC Sep 2024 43.000 put (YBTC240920P00043000)
Long Term Trading Analysis for (WEED)
QDTE Aug 2024 42.000 put (QDTE240816P00042000)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cronos Group stock logo

Cronos Group NASDAQ:CRON

$2.04 +0.02 (+0.74%)
As of 01:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Knight Therapeutics stock logo

Knight Therapeutics TSE:GUD

C$5.79 +0.03 (+0.52%)
As of 12:42 PM Eastern

Knight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic cancer chemotherapy; Fostamatinib for chronic immune thrombocytopenia; Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Trelstar for advanced prostate cancer; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic cancer; Halaven for metastatic breast cancer and soft tissue sarcoma; and Lenvima for advanced renal cell cancer and for differentiated thyroid cancer and unresectable hepatocellular carcinoma. The company provides Ladecvina for multiple myeloma and myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix for metastatic prostate cancer; Karfib for relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; Rembre for chronic myeloid leukemia; Palbocil for breast cancer; Ambisome and Cresemba for fungal infection; Impavido for leishmaniasis; Dolufevir for HIV infection; Exelon for dementia; and Ibsrela for irritable bowel syndrome with constipation. In addition, it offers Salofalk for ulcerative colitis; Ursofalk for biliary cirrhosis; Imvexxy for moderate to severe dyspareunia; Bijuva for vasomotor symptoms; Fibridoner for idiopathic pulmonary fibrosis; Toliscrin DPI for pseudomonas aeruginosa lung infection; Toliscrin 1-2 for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Further, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.

RiverNorth Opportunities Fund stock logo

RiverNorth Opportunities Fund NYSE:RIV

$12.02 +0.08 (+0.63%)
As of 01:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RiverNorth Opportunities Fund, Inc. is a close ended equity mutual fund co- launched and co- managed by ALPS Advisors, Inc. and RiverNorth Capital Management, LLC. It invests in the equity markets. The fund seeks to invest in stocks of companies operating across the diversified sectors. RiverNorth Opportunities Fund, Inc. was formed on December 24, 2015 and is domiciled in the United States.

Roundhill Cannabis ETF stock logo

Roundhill Cannabis ETF BATS:WEED

$10.58 -2.13 (-16.74%)
As of 01:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Roundhill Cannabis ETF (WEED) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of equities and total return swaps that provide exposure to the global cannabis and hemp ecosystem. WEED was launched on Apr 20, 2022 and is managed by Roundhill.